Close Menu

NEW YORK – Agilent Technologies reported after the close of the market on Tuesday that its third quarter 2020 revenues fell 1 percent year over year.

The firm noted that core revenues, which excludes the impact of currency and acquisitions and divestitures in the past 12 months, fell about 3 percent in Q3.

For the three months ended July 31, the firm's revenues fell to $1.26 billion from $1.27 billion in Q3 2019, beating Wall Street analysts' average estimate of $1.21 billion.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

President Donald Trump might not approve the stricter standards the US Food and Drug Administration is developing for authorizing a SARS-CoV-2 vaccine, according to Politico.

Wired reports that Oxitec has now developed a genetically modified fall armyworm.

A large genetic study finds SARS-CoV-2 viruses with a certain variant are spreading more than others, according to the Washington Post.

In Nature this week: sister-chromatid-sensitive chromosome conformation capture approach, and more.